Series - Policy

Policy
BIO advocates on behalf of the industry to public policy makers and influencers in United States and around the world, with these recent webinars representing a sample of BIO’s efforts to inform regulatory and legislative decision making.
Global Out-Licensing Considerations for Manufacturers

June 2, 2026
Speakers: Joe Franklin, Amanda Austin , Grant Castle , Winsome Cheung , Kristie Gurley, Crystal Kuntz, Sibel Yilmaz

The biopharmaceutical ecosystem is facing heightened uncertainty, driven by funding constraints, regulatory shifts, and policy reforms—including pricing pressures and the potential expansion of international reference pricing. These dynamics are reshaping dealmaking and raising…

Upcoming
Global Pharma Manufacturing image
Webinars
  • Show All
Results
Raising Capital
Dec 8, 2025
Partnering in motion5
Donna L. LaVoie, Assad Aslam, Bernard V. Fallon, Shiv Krishnan, PhD, Nicola La Monica, PhD, Raphaël G. Ognar, MSc, MBA, Mackensie Vernetti, Brian Wiley
December 8, 2025
Policy
Nov 20, 2025
DTC media rules image
Ilyssa Levins-Pimienta, Robert Dean, Howard Dorfman
November 20, 2025
Raising Capital
Oct 30, 2025
BIO Partnering @JPM Week 2025_appointments in action
BIO Benefits
Oct 16, 2025
Women operating high tech lab equipment
Jeff Vallerga, Joe Dragavon, Ric Kunnert, Rob Salmon
October 16, 2025
BIO Benefits
Sep 12, 2025
Biotechnology is a National Security Asset
Jeff Vallerga, Andy Wilson
September 12, 2025
BIO Benefits
Sep 11, 2025
Travel Operations Logistics image
Jeff Vallerga, Matt Curry, Sarah Glazier, Alina Mencias, Dave Tucker
September 11, 2025
BIO Benefits
Sep 10, 2025
data-migration-PSC-Software
Tamy Dalal, Russell Allen, Ryan Ciarcia, Jon Napoli
September 10, 2025
BIO Benefits
Sep 9, 2025
Finance-and-Admin
Jeff Vallerga, Jose Arellano, Max Conaboy, Gaby Levey, Natalie Marquess
September 9, 2025
BIO Benefits
Sep 8, 2025
women-scientist-looking-at-research
Jeff Vallerga, Brandon Clough, Carrie Kleinle, Ric Kunnert, Rob Salmon
September 8, 2025